Profile
GCTK ISRG BDX BDXA ALC RMD
Company Name GlucoTrack, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $1.08M $173.36B $59.94B $55.91B $39.26B $37.85B
Employees 0.01K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Paul V. Goode David J. Rosa Thomas E. Polen Jr. - David J. Endicott Michael J. Farrell
Ratings
GCTK ISRG BDX BDXA ALC RMD
Quant Rating Score 3 1 3 5 3 4
Quant Rating Neutral Strong Sell Neutral Strong Buy Neutral Buy
Trading
GCTK ISRG BDX BDXA ALC RMD
Last Close $5.2 $546.71 $190.98 $59.24 $76.61 $244.71
High 52 $10.59 $610.45 $249.08 $59.24 $98.3 $293.73
Low 52 $0.06 $429.59 $165.15 $59.24 $72.05 $204.58
Price vs. 52 Week High -50.9 % -10.44 % -23.33 % 0 % -22.07 % -16.69 %
Price vs. 52 Week Low 8566.67 % 27.26 % 15.64 % 0 % 6.33 % 19.62 %
Total Return
GCTK ISRG BDX BDXA ALC RMD
1 Month Return -21.92 % 22.54 % 0.99 % 0 % 2 % -8.72 %
3 Month Return -9.09 % 13.64 % -2.06 % 0 % -13.07 % -14.47 %
6 Month Return 3364.36 % -3 % 8.88 % 0 % -14.72 % -2.77 %
9 Month Return 1045.37 % -9.02 % -15.17 % 0 % -14.35 % 6.13 %
YTD Return 1294.1 % 4.74 % -15.82 % 0 % -9.75 % 7.01 %
1 Year Return 1940.82 % 1.46 % -14.22 % 0 % -10.32 % 2.77 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
GCTK ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 1.99 % 2.02 % 0.42 % 0.87 %
Dividend Paid and Capex Coverage Ration (TTM) -341.05 % 4.3 % 1.75 % 1.75 % 3.02 % 4.31 %
Dividend Per Share (TTM) - - 4.17 % 4.17 % 0.33 % 2.26 %
Payout Ratio (TTM) - - 71.28 % 71.28 % 15.49 % 22.31 %
Profitability
GCTK ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM - 66.06 % 45.44 % 45.44 % 55.12 % 60.08 %
Return on Assets TTM -311.87 % 14.76 % 3.03 % 3.03 % 3.32 % 17.31 %
Return on Equity TTM -2659.19 % 16.72 % 6.63 % 6.63 % 4.77 % 25.13 %
Return on Capital Employed TTM -549.85 % 16.78 % 5.48 % 5.48 % 5.06 % 24.74 %
Net Income Per EBT TTM 100 % 86.25 % 89.16 % 89.16 % 84.1 % 82.6 %
EBT Per Ebit TTM 157.1 % 112.42 % 73 % 73 % 86.34 % 99.79 %
EBIT Per Revenue TTM - 29.27 % 11.8 % 11.8 % 14.16 % 33.18 %
Cash Flow To Debt Ratio TTM -35810 % - 17.88 % 17.88 % 39.18 % 222.53 %
Receivables Turnover TTM - 7.27 7.29 7.29 5.26 5.49
Payables Turnover TTM 0.02 11.73 - - 5.11 7.87
Inventory Turnover TTM - 1.92 3.06 3.06 1.88 2.22
Fixed Asset Turnover TTM - 195.4 % 312.12 % 312.12 % 198.09 % 724.52 %
Asset Turnover TTM - 52.01 % 39.47 % 39.47 % 32.34 % 63.28 %
Operating Cash Flow Per Share TTM -15.93 8.34 11.97 11.97 4.16 12.86
Free Cash Flow Per Share TTM -15.97 6.4 9.32 9.32 3.11 12.06
Cash Per Share TTM 874.91 % 1383.15 % 299.71 % 299.71 % 303.41 % 944.79 %
Operating Cash Flow Sales Ratio TTM - 29.42 % 15.71 % 15.71 % 20.13 % 35.82 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.29 % 76.72 % 77.84 % 77.84 % 74.75 % 93.83 %
Cash Flow Coverage Ratios TTM -35810 % - 17.88 % 17.88 % 39.18 % 222.53 %
Price To Free Cash Flows Ratio TTM -0.08 76.32 22.45 22.08 25.61 21.42
Price To Operating Cash Flows Ratio TTM -0.12 58.52 17.55 17.26 19.09 20.16
Price Cash Flow Ratio TTM -0.12 58.52 17.55 17.26 19.09 20.16
Income Statement (TTM)
GCTK ISRG BDX BDXA ALC RMD
Revenue $0B $10.06B $21.84B $21.84B $9.91B $5.15B
Gross Profit $-0B $6.66B $9.92B $9.92B $5.51B $3.05B
Gross Profit Ratio 0% 66.13% 45.44% 45.44% 55.61% 59.36%
EBITDA $-0.02B $3.31B $4.96B $4.96B $2.68B $1.91B
Net Income $-0.02B $2.86B $1.68B $1.68B $1.02B $1.4B
EPS Diluted 60.76 7.87 5.83 5.83 2.05 9.51
Balance Sheet (MRQ)
GCTK ISRG BDX BDXA ALC RMD
Long Term Debt $0B $0.11B $17.62B $17.62B $4.97B $0.81B
Total Liabilities $0.02B $2.31B $29.94B $29.94B $8.79B $2.21B
Total Equity $-0.01B $16.53B $25.39B $25.39B $21.55B $5.97B
Total Investments $0B $7.05B $0.01B $0.01B $0.91B $0.09B
Total Debt $0B $0.15B $19.18B $19.18B $5.14B $0.85B
Total Assets $0.01B $18.84B $55.33B $55.33B $30.35B $8.17B
Cash Flow Statement (TTM)
GCTK ISRG BDX BDXA ALC RMD
Net Income $-0.02B $2.34B $1.68B $1.68B $1.02B $1.4B
Inventory $0B $-0.83B $-0.41B $-0.41B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.2B $-1.2B $-0.13B $-0.31B
Operating Cash Flow $-0.01B $2.42B $3.43B $3.43B $2.08B $1.75B
Capital Expenditure $-0B $-1.11B $-0.76B $-0.76B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 78.83
ANGO AngioDynamics, Inc. 10.56
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 134.31
ATRC AtriCure, Inc. 37.11
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.26
AZTA Azenta, Inc. 28.72
BAX Baxter International Inc. 21.73
BDX Becton, Dickinson and Company 210.02
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 17
BLFS BioLife Solutions, Inc. 22.43
COO The Cooper Companies, Inc. 82.1
DXR Daxor Corporation 12.345
EKSO Ekso Bionics Holdings, Inc. 10.41
Unlock